September 11, 2017 07:38 AM EDT
News Briefing

Sum­mit wins $62M BAR­DA con­tract, shares surge; No­var­tis adds new CGRP da­ta

Shehla Shakoor

Managing Director

⇨ Shares of Sum­mit Ther­a­peu­tics $SMMT shot up this morn­ing af­ter the biotech re­port­ed that it had won a $62 mil­lion con­tract from …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times